Elastin Repair Is a Sequencing Problem
Repairing vascular elastin networks is strongly limited by damaged extracellular matrix; clearing stiff, protease-resistant, inflammation-provoking debris is often a prerequisite for meaningful reconstruction.
Arterial elastin repair is a sequencing problem. In the Eternal Search classification, "repairing" (fix damage in place) and "clearing" (remove harmful accumulations) are separate strategies. For arterial elastin, repair without prior clearing accomplishes little. The system rates this dependency as high-confidence.
The repair approach combines elastogenesis and elastic-fiber assembly drivers (tropoelastin, LOX/LOXL1, fibulin-5) with elastase and MMP inhibition to rebuild elastic lamellae and restore vascular compliance.
The extracellular matrix in aged arteries is already damaged. Collagen and elastin are cross-linked; the debris is stiff, resists proteases, and drives inflammation. That tissue will not fix itself. Clearing means removing or remodeling damaged matrix proteins, especially cross-linked collagen and elastin. While fragmentation and calcified debris remain, meaningful elastin reconstruction is often out of reach.
The system's rationale for this dependency is analytical; no anchor quotes from publications are stored yet.
The dependency between elastin repair and damaged-ECM clearing is rated high-confidence in the system but has no in-vivo proof-of-concept and no anchor citation stored; it surfaces a concrete sequencing bottleneck (clearing before rebuilding) that is well-supported by matrix biology yet absent from both the therapeutic pipeline and most longevity discussions.